Related Experiment Video
Updated: Jun 17, 2026
08:21
A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
Published on: October 26, 2020
[Renin inhibition and the kidney]
1Department of Internal Medicine, Istanbul Medicine Faculty of Istanbul University, Istanbul, Turkey. ecder@istanbul.edu.tr
Summary
The renin-angiotensin aldosterone system accelerates kidney failure. Direct renin inhibitors like aliskiren show promise in slowing chronic kidney disease progression and reducing proteinuria, especially in diabetic nephropathy.
Area of Science:
- Nephrology
- Pharmacology
- Cardiovascular Research
Context:
- Chronic kidney disease (CKD) progression is linked to the detrimental effects of the renin-angiotensin aldosterone system (RAAS).
- Angiotensin-converting enzyme inhibitors (ACEi) and angiotensin-receptor blockers (ARBs) are established RAAS inhibitors that slow kidney disease progression.
- Aliskiren represents a novel therapeutic class as a direct renin inhibitor (DRI), targeting the RAAS at its initial step.
Purpose:
- To review the renoprotective effects of aliskiren, a direct renin inhibitor.
- To evaluate aliskiren's efficacy in slowing the progression of renal failure and reducing proteinuria in patients with chronic kidney disease, particularly diabetic nephropathy.
Summary:
- The renin-angiotensin aldosterone system plays a critical role in the advancement of renal failure.
- Experimental studies indicate aliskiren possesses significant renoprotective properties.
- Clinical data suggest aliskiren, when added to standard care, provides additional antiproteinuric benefits in patients with diabetic nephropathy.
Impact:
- Aliskiren's mechanism as a direct renin inhibitor offers a distinct approach to RAAS blockade.
- Further clinical studies are anticipated to clarify the optimal role of direct renin inhibitors in managing target organ damage in CKD.
- Findings contribute to understanding therapeutic strategies for preserving kidney function in patients with CKD.
Related Concept Videos
01:25Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
01:33Hormonal Regulation
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
01:13Introduction to Urinary System
The urinary system consists of two kidneys, two ureters, the urinary bladder, and the urethra.
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...